Information for Public Companies That Would Like to Participate in Spotlight Panel Discussions

Mid-, small – and micro-cap companies in the following categories are invited to apply to participate at BioFuture:

• Small/large molecule R&D therapeutic
• Platform
• Tool
• Delivery
• Molecular diagnostic and personalized medicine
• Research focused service providers
• Digital Medicine
• Artificial Intelligence (AI)

Every company attendee enjoys full access to our exclusive one-to-one partnering system.

Priority review deadlines

Apply early and receive priority review and presentation slot placements.

• July 28: Review Round #1
• August 9: Review Round #2
• August 23: Review Round #3
• September 6: Review Round #4
• September 20: Review Round #5
• October 4: Review Round #6
  Final call for all applications: October 10

Public company participation fee:

• $2,950 Early Bird Registration Fee (Ends September 15)
• $3,150 Regular Registration Fee (Ends October 13)
• $3,350 Onsite Registration Fee
• This fee includes access for one (1) presenter. Additional company employees may attend for $500 each.